AstraZeneca Pharma - we had a pilot position @1940 and we added more today@2136
3 yr average sales growth - 4%
3 yr average profit growth - 120%
3 yr average margin growth - 200%
The sales growth is not very impressive however the company was making losses from 2013-2015 and it has turned around since 2016. We will be watching the upcoming quarters for a further cue in the improvement of sales and we will also look for guidance from the annual reports.
3 yr average sales growth - 4%
3 yr average profit growth - 120%
3 yr average margin growth - 200%
The sales growth is not very impressive however the company was making losses from 2013-2015 and it has turned around since 2016. We will be watching the upcoming quarters for a further cue in the improvement of sales and we will also look for guidance from the annual reports.
Value doesn't move stock prices, people do by placing buy orders. Value is only part of the equation. Ultimately, you need demand - Mark Minervini
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, alım satım veya diğer türden tavsiye veya öneriler anlamına gelmez ve teşkil etmez. Kullanım Koşulları bölümünde daha fazlasını okuyun.
Value doesn't move stock prices, people do by placing buy orders. Value is only part of the equation. Ultimately, you need demand - Mark Minervini
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, alım satım veya diğer türden tavsiye veya öneriler anlamına gelmez ve teşkil etmez. Kullanım Koşulları bölümünde daha fazlasını okuyun.